Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (51-60 of 577) with videos related to

Pageof 58
Sort By:
Molecules (Basel, Switzerland)|December 31, 2025
From Elixirs to Geroscience: A Historical and Molecular Perspective on Anti-Aging MedicineGiuseppe Rosario Pietro Nicoletti, Katia Mangano, Ferdinando Nicoletti, et al.
Advances in Experimental Medicine and Biology|February 11, 2003
Neuroprotective activity of metabotropic glutamate receptor ligandsPeter J Flor, Giuseppe Battaglia, Ferdinando Nicoletti, et al.
Oncotarget|April 14, 2011
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicityLinda S Steelman, Alberto M Martelli, Ferdinando Nicoletti, et al.
Neuropharmacology|December 3, 2016
Metabotropic glutamate receptors, 5 years onGraham L Collingridge, Denise Manahan-Vaughan, Ferdinando Nicoletti, et al.
Molecular Pharmacology|April 21, 2011
Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brainFrancesco Matrisciano, Erbo Dong, David Peter Gavin, et al.
Cells|January 24, 2025
Valproate-Induced Model of Autism in Adult Zebrafish: A Systematic ReviewDiletta Camussi, Maria Marchese, Ferdinando Nicoletti, et al.
Acta Histochemica|October 30, 2015
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysisPaolo Fagone, Ferdinando Nicoletti, Giada Maria Vecchio, et al.
Current Opinion in Pharmacology|December 16, 2014
Metabotropic glutamate receptors as drug targets: what's new?Ferdinando Nicoletti, Valeria Bruno, Richard Teke Ngomba, et al.
Current Neuropharmacology|January 28, 2016
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A ReviewFrancesco Matrisciano, Isabella Panaccione, Danis R Grayson, et al.
Molecular Medicine (Cambridge, Mass.)|November 29, 2002
An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cellsGianpaolo Papaccio, Ferdinando Nicoletti, Francesco A Pisanti, et al.
Pageof 58

Showing results (51-60 of 577) with videos related to

Sort By:
Pageof 58
Molecules (Basel, Switzerland)|December 31, 2025
From Elixirs to Geroscience: A Historical and Molecular Perspective on Anti-Aging MedicineGiuseppe Rosario Pietro Nicoletti, Katia Mangano, Ferdinando Nicoletti, et al.
Advances in Experimental Medicine and Biology|February 11, 2003
Neuroprotective activity of metabotropic glutamate receptor ligandsPeter J Flor, Giuseppe Battaglia, Ferdinando Nicoletti, et al.
Oncotarget|April 14, 2011
Exploiting p53 status to enhance effectiveness of chemotherapy by lowering associated toxicityLinda S Steelman, Alberto M Martelli, Ferdinando Nicoletti, et al.
Neuropharmacology|December 3, 2016
Metabotropic glutamate receptors, 5 years onGraham L Collingridge, Denise Manahan-Vaughan, Ferdinando Nicoletti, et al.
Molecular Pharmacology|April 21, 2011
Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brainFrancesco Matrisciano, Erbo Dong, David Peter Gavin, et al.
Cells|January 24, 2025
Valproate-Induced Model of Autism in Adult Zebrafish: A Systematic ReviewDiletta Camussi, Maria Marchese, Ferdinando Nicoletti, et al.
Acta Histochemica|October 30, 2015
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysisPaolo Fagone, Ferdinando Nicoletti, Giada Maria Vecchio, et al.
Current Opinion in Pharmacology|December 16, 2014
Metabotropic glutamate receptors as drug targets: what's new?Ferdinando Nicoletti, Valeria Bruno, Richard Teke Ngomba, et al.
Current Neuropharmacology|January 28, 2016
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A ReviewFrancesco Matrisciano, Isabella Panaccione, Danis R Grayson, et al.
Molecular Medicine (Cambridge, Mass.)|November 29, 2002
An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cellsGianpaolo Papaccio, Ferdinando Nicoletti, Francesco A Pisanti, et al.
Pageof 58